BriaCell Therapeutics Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$4,791,466 over the previous period. Total operating expenses were $32,725,534.

Profit Margin

BriaCell Therapeutics Corp. (NASDAQ:BCTX): Profit margin
2015 0 -2.68M
2016 0 -1.69M
2017 0 -2.58M
2018 0 1.06M
2019 0 602.68K
2020 0 1.38M
2021 0 -2.89M
2022 0 -11.58M
2023 0 -20.30M
2024 0 -4.79M

BCTX Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000000000
Cost of revenue
82.58K15.52K15.14K15.57K13.99K14.27K0000
Gross profit
-82.58K-15.52K-15.14K-15.57K-13.99K-14.27K0000
Operating exp.
Research and development
26.75M15.33M8.02M1.31M2.22M3.73M2.38M1.70M723.42K105.82K
Selling and marketing
-178.93K000000000
Total operating expenses
32.72M23.27M-3.38K-3.68M-1.38M-946.42K-1.06M2.58M1.66M1.44M
Operating income
-32.80M-23.27M-15.28M3.68M1.38M946.42K-3.81M-2.58M-1.66M-1.44M
Other income (expenses), net
28.01M2.96M3.73M6.58M-85.09K343.74K-331.39K634.11K-32.40K-1.24M
Income before tax
-4.79M-20.30M-11.54M3.68M1.38M946.42K1.06M-2.58M-1.69M-2.68M
Income tax expense
62.85K-152.62K30.73K6.58M-72.25K343.74K1.59M638.59K547.96K2.04M
Net income
-4.79M-20.30M-11.58M-2.89M1.38M602.68K1.06M-2.58M-1.69M-2.68M
Earnings per share
Basic EPS
-0.29-1.3-0.75-0.641.941.042.49-7.61-5.88-10.76
Diluted EPS
-0.29-1.3-0.75-0.641.941.042.49-7.32-5.88-10.76
Data sourceData sourceData source